Rocket Lab has officially graduated from niche player to Prime Contractor following the massive $816 million SDA contract, validating my bullish thesis that has delivered a 1,200%+ return. Vertical ...

The latest price target for Rocket Lab (NASDAQ:RKLB) was reported by Keybanc on January 15, 2026. The analyst firm set a price target for $0.00 expecting RKLB to fall to within 12 months (a possible ...

Visceral leishmaniasis (VL) is a severe infectious disease caused by a protozoan parasite: Leishmania donovani in East Africa and the Indian subcontinent and Leishmania infantum in Latin America and ...